Header Logo

Allison Naleway

Concepts (441)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Vaccination
93
2026
725
10.660
Why?
Influenza Vaccines
60
2026
300
9.610
Why?
Influenza, Human
55
2026
292
9.050
Why?
Pregnancy Complications, Infectious
26
2025
158
5.600
Why?
Papillomavirus Vaccines
17
2023
113
3.800
Why?
Humans
228
2026
16832
3.780
Why?
Adolescent
109
2026
3464
3.680
Why?
Adult
145
2026
7255
3.670
Why?
Young Adult
98
2026
2456
3.560
Why?
Female
178
2026
12193
3.480
Why?
Vaccination Coverage
8
2026
68
3.380
Why?
Pregnancy
61
2026
1555
3.380
Why?
Papillomavirus Infections
15
2023
141
3.240
Why?
Child
73
2026
2433
3.030
Why?
United States
90
2026
3858
2.820
Why?
Diphtheria-Tetanus-acellular Pertussis Vaccines
17
2026
98
2.710
Why?
Hospitalization
33
2026
816
2.630
Why?
Vaccines
17
2025
225
2.610
Why?
Infant
62
2026
1212
2.370
Why?
Rotavirus Vaccines
7
2026
53
2.290
Why?
Male
111
2026
9556
2.200
Why?
Middle Aged
80
2026
7515
2.080
Why?
Child, Preschool
49
2026
1430
1.830
Why?
Retrospective Studies
45
2026
2463
1.720
Why?
Emergency Service, Hospital
18
2025
393
1.670
Why?
Uterine Cervical Neoplasms
8
2022
130
1.620
Why?
Oregon
18
2026
168
1.560
Why?
Health Personnel
12
2025
132
1.510
Why?
Adverse Drug Reaction Reporting Systems
15
2019
97
1.480
Why?
Viral Vaccines
3
2023
12
1.310
Why?
Gastroenteritis
4
2024
16
1.310
Why?
Rotavirus Infections
4
2026
33
1.270
Why?
Respiratory Syncytial Virus Infections
3
2025
40
1.260
Why?
Prospective Studies
35
2026
1186
1.250
Why?
Influenza A Virus, H1N1 Subtype
13
2025
56
1.240
Why?
Health Knowledge, Attitudes, Practice
8
2025
352
1.230
Why?
Antibodies, Viral
12
2026
70
1.170
Why?
Respiratory Syncytial Virus, Human
3
2025
29
1.140
Why?
Aged
45
2026
5901
1.140
Why?
Patient Acceptance of Health Care
11
2025
353
1.140
Why?
Case-Control Studies
25
2026
995
1.110
Why?
Cohort Studies
42
2025
2396
1.090
Why?
Delivery of Health Care, Integrated
9
2024
515
1.090
Why?
Respiratory Syncytial Virus Vaccines
2
2025
12
1.080
Why?
Infant, Newborn
32
2026
828
1.070
Why?
Vaccines, Inactivated
18
2025
73
1.050
Why?
Condylomata Acuminata
2
2020
16
1.040
Why?
Rotavirus
3
2022
17
1.030
Why?
Drug-Related Side Effects and Adverse Reactions
8
2022
104
0.960
Why?
Whooping Cough
8
2026
71
0.940
Why?
Incidence
21
2025
1229
0.930
Why?
Seasons
13
2026
114
0.930
Why?
Washington
10
2026
376
0.920
Why?
Hepatitis B Vaccines
3
2018
44
0.910
Why?
Intention
1
2025
28
0.900
Why?
Parents
3
2025
298
0.880
Why?
Antibodies, Monoclonal
1
2025
24
0.860
Why?
Premature Birth
10
2024
133
0.840
Why?
Norovirus
1
2024
1
0.830
Why?
Immunization, Secondary
8
2022
58
0.820
Why?
Databases, Factual
11
2025
294
0.810
Why?
Complex Regional Pain Syndromes
1
2023
2
0.780
Why?
Ambulatory Care
8
2026
205
0.760
Why?
Pregnancy Outcome
9
2024
160
0.750
Why?
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
3
2017
31
0.690
Why?
Surveys and Questionnaires
10
2025
1204
0.690
Why?
Immunization Schedule
10
2026
127
0.680
Why?
Hepatitis A Vaccines
2
2019
15
0.680
Why?
Vaccines, Combined
13
2024
80
0.670
Why?
Inflammatory Bowel Diseases
1
2021
23
0.670
Why?
Smallpox Vaccine
4
2023
6
0.640
Why?
Seizures, Febrile
7
2017
42
0.640
Why?
Pregnancy Complications
5
2017
202
0.630
Why?
Prenatal Care
6
2017
123
0.630
Why?
RNA, Messenger
10
2024
66
0.620
Why?
Hepatitis A Virus, Human
1
2019
5
0.610
Why?
Hepatitis A
1
2019
11
0.610
Why?
Chickenpox Vaccine
9
2020
91
0.600
Why?
Papillomaviridae
4
2020
58
0.600
Why?
Age Factors
12
2026
814
0.580
Why?
Family Characteristics
4
2026
69
0.560
Why?
Pregnant Women
4
2021
41
0.560
Why?
Influenza A Virus, H3N2 Subtype
8
2026
21
0.560
Why?
Venous Thromboembolism
2
2017
55
0.560
Why?
Abortion, Spontaneous
5
2021
49
0.560
Why?
Vaccines, Synthetic
9
2025
39
0.560
Why?
Herpes Zoster
4
2023
80
0.550
Why?
Syncope
1
2018
11
0.550
Why?
Acute Pain
1
2018
10
0.550
Why?
Chorioamnionitis
4
2023
18
0.530
Why?
Feedback
1
2017
22
0.530
Why?
Tetanus
3
2026
23
0.530
Why?
Sexual Partners
1
2017
34
0.530
Why?
Population Surveillance
9
2019
242
0.520
Why?
Risk Assessment
13
2020
1047
0.520
Why?
Time Factors
13
2022
989
0.520
Why?
Risk Factors
21
2026
3108
0.520
Why?
Product Surveillance, Postmarketing
8
2016
99
0.510
Why?
Asthma
4
2017
375
0.500
Why?
Fever
5
2020
52
0.500
Why?
Aged, 80 and over
19
2026
1887
0.470
Why?
Pregnancy Rate
1
2015
7
0.440
Why?
Vaccines, Attenuated
7
2023
44
0.440
Why?
Rural Population
4
2005
58
0.430
Why?
Viral Load
4
2026
141
0.430
Why?
Photosensitivity Disorders
2
2006
3
0.430
Why?
Precancerous Conditions
1
2015
45
0.430
Why?
Mass Vaccination
4
2019
22
0.410
Why?
Bacterial Vaccines
1
2014
9
0.410
Why?
Pandemics
5
2023
289
0.410
Why?
Measles-Mumps-Rubella Vaccine
5
2020
64
0.410
Why?
Dermatitis, Atopic
3
2005
18
0.410
Why?
Seizures
4
2014
28
0.390
Why?
Critical Illness
2
2023
53
0.370
Why?
Risk
13
2017
453
0.360
Why?
Respiratory Tract Infections
4
2026
58
0.350
Why?
Database Management Systems
3
2020
14
0.330
Why?
Diphtheria-Tetanus-Pertussis Vaccine
2
2016
24
0.330
Why?
Pericarditis
2
2022
11
0.320
Why?
Myocarditis
2
2022
14
0.320
Why?
Congenital Abnormalities
4
2017
26
0.310
Why?
Anemia, Hemolytic
1
2009
2
0.300
Why?
Infant, Small for Gestational Age
4
2024
55
0.300
Why?
Patient Compliance
2
2012
262
0.290
Why?
Epidemiological Monitoring
2
2019
21
0.290
Why?
Prevalence
10
2019
785
0.290
Why?
Electronic Health Records
6
2023
702
0.290
Why?
Hemagglutinin Glycoproteins, Influenza Virus
2
2025
2
0.280
Why?
Immunity, Humoral
2
2025
5
0.280
Why?
Herpes Zoster Vaccine
2
2023
60
0.280
Why?
Antiviral Agents
4
2026
92
0.270
Why?
Lupus Erythematosus, Systemic
2
2005
7
0.270
Why?
Immunoglobulin G
2
2025
33
0.270
Why?
Agriculture
2
2005
7
0.260
Why?
Centers for Disease Control and Prevention (U.S.)
5
2014
32
0.260
Why?
Eczema
2
2006
7
0.260
Why?
Intussusception
2
2014
16
0.260
Why?
Cross-Sectional Studies
5
2026
1233
0.260
Why?
Specimen Handling
3
2022
23
0.250
Why?
Measles
2
2020
25
0.250
Why?
Alphapapillomavirus
2
2020
13
0.250
Why?
Smallpox
2
2005
4
0.250
Why?
Sick Role
1
2006
9
0.250
Why?
Enterovirus Infections
1
2026
3
0.240
Why?
Enterovirus D, Human
1
2026
3
0.240
Why?
European Continental Ancestry Group
3
2019
400
0.240
Why?
Proteome
1
2026
3
0.240
Why?
Hemagglutination Inhibition Tests
6
2025
8
0.240
Why?
Managed Care Programs
5
2013
275
0.240
Why?
Genome, Viral
1
2026
8
0.240
Why?
Stillbirth
3
2021
29
0.240
Why?
Genetic Variation
1
2026
67
0.230
Why?
Multivariate Analysis
6
2017
489
0.230
Why?
Cost of Illness
1
2026
90
0.230
Why?
Immunity, Cellular
1
2025
5
0.230
Why?
B-Lymphocytes
1
2025
5
0.230
Why?
Metapneumovirus
1
2025
7
0.220
Why?
Paramyxoviridae Infections
1
2025
8
0.220
Why?
Computer Simulation
1
2025
84
0.210
Why?
Emergency Responders
2
2021
4
0.210
Why?
Logistic Models
8
2025
796
0.210
Why?
Rhinitis, Allergic, Seasonal
1
2004
3
0.210
Why?
Social Determinants of Health
1
2024
39
0.200
Why?
Hypertension, Pregnancy-Induced
2
2014
40
0.200
Why?
Immunization Programs
4
2013
65
0.200
Why?
Mental Recall
1
2003
27
0.200
Why?
Upper Extremity
1
2023
5
0.200
Why?
Antibody Formation
3
2024
7
0.190
Why?
Internet
2
2023
207
0.190
Why?
Peripartum Period
1
2023
2
0.190
Why?
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
1
2022
4
0.190
Why?
Quality of Life
1
2006
477
0.190
Why?
Respiratory Tract Diseases
2
2020
21
0.190
Why?
Mental Disorders
2
2024
248
0.190
Why?
RNA, Messenger, Stored
1
2022
3
0.190
Why?
Public Health Surveillance
2
2019
42
0.190
Why?
Typhoid-Paratyphoid Vaccines
1
2022
3
0.190
Why?
Social Class
2
2013
106
0.190
Why?
Travel
1
2022
10
0.190
Why?
Lyme Disease
1
2002
4
0.180
Why?
Healthcare Disparities
1
2024
213
0.180
Why?
Immunocompromised Host
1
2021
16
0.180
Why?
Insurance, Health
2
2021
167
0.170
Why?
Occupations
1
2021
15
0.170
Why?
Feasibility Studies
2
2018
108
0.170
Why?
Attitude of Health Personnel
2
2013
197
0.170
Why?
Occupational Diseases
1
2021
33
0.170
Why?
Antibodies, Neutralizing
3
2026
13
0.160
Why?
Pneumococcal Vaccines
2
2013
67
0.160
Why?
Wisconsin
4
2005
12
0.160
Why?
Influenza A virus
3
2016
13
0.160
Why?
Interviews as Topic
3
2017
305
0.160
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2016
21
0.160
Why?
Herpesvirus 3, Human
2
2023
40
0.160
Why?
Pilot Projects
2
2018
210
0.160
Why?
Mumps
1
2020
13
0.160
Why?
Northwestern United States
1
2020
53
0.160
Why?
Chickenpox
1
2020
35
0.150
Why?
Preconception Care
2
2017
43
0.150
Why?
Contraindications
2
2014
13
0.150
Why?
Coronavirus Infections
1
2020
49
0.150
Why?
Diphtheria-Tetanus Vaccine
2
2009
3
0.150
Why?
Pneumonia, Viral
1
2020
56
0.150
Why?
Immunity, Herd
1
2019
4
0.150
Why?
Child Development
1
2020
58
0.150
Why?
Tetanus Toxoid
2
2015
11
0.140
Why?
Follow-Up Studies
7
2018
1058
0.140
Why?
Immunization
2
2021
70
0.140
Why?
Patient Comfort
1
2018
3
0.140
Why?
Cryotherapy
1
2018
4
0.140
Why?
Health Status
2
2013
256
0.140
Why?
Regression Analysis
2
2015
261
0.140
Why?
Hepatitis B
1
2018
43
0.140
Why?
Infant Mortality
1
2018
14
0.140
Why?
Patient Selection
1
2019
175
0.130
Why?
Mucocutaneous Lymph Node Syndrome
2
2014
18
0.130
Why?
Treatment Outcome
5
2021
1098
0.130
Why?
Uterine Cervical Dysplasia
1
2017
10
0.130
Why?
Gestational Age
3
2013
118
0.130
Why?
Pneumonia
1
2017
47
0.130
Why?
Real-Time Polymerase Chain Reaction
2
2014
8
0.130
Why?
Measles Vaccine
1
2017
17
0.130
Why?
Infant, Newborn, Diseases
1
2017
34
0.130
Why?
Health Status Disparities
2
2021
145
0.130
Why?
Health Communication
1
2017
16
0.120
Why?
Off-Label Use
2
2013
13
0.120
Why?
Intensive Care Units
1
2017
102
0.120
Why?
Physician's Role
1
2017
25
0.120
Why?
Cause of Death
2
2018
171
0.120
Why?
Medical Records Systems, Computerized
2
2009
68
0.120
Why?
Encephalomyelitis, Acute Disseminated
1
2016
4
0.120
Why?
Myelitis, Transverse
1
2016
4
0.120
Why?
Cluster Analysis
1
2017
88
0.120
Why?
Health Maintenance Organizations
3
2013
358
0.120
Why?
Drug Utilization
2
2013
112
0.120
Why?
Communication
1
2017
183
0.120
Why?
Dose-Response Relationship, Immunologic
1
2016
2
0.120
Why?
Physicians, Primary Care
1
2017
63
0.120
Why?
Data Collection
2
2013
223
0.120
Why?
Mortality
2
2013
116
0.120
Why?
Proteomics
2
2026
10
0.110
Why?
Aluminum
1
2015
15
0.110
Why?
Breast Feeding
1
2017
112
0.110
Why?
Adjuvants, Immunologic
1
2015
19
0.110
Why?
Propensity Score
3
2025
78
0.110
Why?
Health Behavior
2
2014
332
0.110
Why?
Algorithms
2
2017
210
0.110
Why?
Immunosuppressive Agents
1
2015
14
0.110
Why?
Nose
1
2015
2
0.110
Why?
Turbinates
1
2015
2
0.110
Why?
Age Distribution
3
2017
221
0.110
Why?
Severity of Illness Index
5
2017
410
0.110
Why?
Environmental Exposure
1
2015
120
0.110
Why?
Hypersensitivity
2
2013
20
0.110
Why?
Sentinel Surveillance
1
2014
12
0.110
Why?
Prenatal Exposure Delayed Effects
1
2017
206
0.110
Why?
Clinical Protocols
1
2014
38
0.100
Why?
Demography
3
2022
89
0.100
Why?
Sensitivity and Specificity
5
2016
291
0.100
Why?
Eclampsia
1
2014
13
0.100
Why?
California
6
2019
2244
0.100
Why?
Yellow fever virus
1
2013
1
0.100
Why?
Yellow Fever Vaccine
1
2013
1
0.100
Why?
Yellow Fever
1
2013
2
0.100
Why?
Molecular Diagnostic Techniques
1
2013
7
0.100
Why?
Obstetric Labor Complications
1
2013
11
0.100
Why?
Pre-Eclampsia
1
2014
41
0.100
Why?
Cell Culture Techniques
2
2024
5
0.100
Why?
Confounding Factors (Epidemiology)
1
2013
77
0.100
Why?
Preventive Health Services
1
2014
142
0.100
Why?
Carcinoma in Situ
1
2013
12
0.100
Why?
Cervical Intraepithelial Neoplasia
1
2013
16
0.100
Why?
Drug Eruptions
1
2013
4
0.100
Why?
Oseltamivir
1
2012
3
0.090
Why?
Diphtheria
1
2012
13
0.090
Why?
HIV Infections
1
2019
708
0.090
Why?
RNA, Viral
2
2022
66
0.090
Why?
Comorbidity
3
2017
516
0.090
Why?
Hospital Mortality
2
2023
134
0.090
Why?
Stroke
2
2019
297
0.090
Why?
Health Services
1
2013
100
0.090
Why?
Denmark
1
2012
14
0.090
Why?
Medical Records
3
2008
85
0.090
Why?
Influenza B virus
2
2026
13
0.090
Why?
Laboratories
2
2021
17
0.090
Why?
Sex Factors
3
2013
560
0.090
Why?
Adenocarcinoma
1
2013
160
0.090
Why?
Focus Groups
1
2012
140
0.090
Why?
Drug Prescriptions
1
2012
137
0.080
Why?
Skin
1
2011
12
0.080
Why?
School Health Services
1
2011
39
0.080
Why?
Guideline Adherence
1
2012
155
0.080
Why?
Safety
2
2011
43
0.080
Why?
Qualitative Research
1
2012
288
0.080
Why?
Diabetes, Gestational
1
2014
330
0.080
Why?
Diphtheria Toxoid
1
2009
3
0.070
Why?
Registries
1
2011
449
0.070
Why?
International Classification of Diseases
3
2017
84
0.070
Why?
Brain Ischemia
1
2009
36
0.070
Why?
Meningococcal Vaccines
1
2009
40
0.070
Why?
Pneumococcal Infections
1
2009
43
0.070
Why?
Herpes Simplex
1
2008
7
0.070
Why?
Longitudinal Studies
2
2025
653
0.070
Why?
Natural Language Processing
2
2009
60
0.070
Why?
Research Design
2
2025
319
0.070
Why?
Genotype
2
2019
198
0.060
Why?
Odds Ratio
2
2019
569
0.060
Why?
Medication Adherence
1
2009
235
0.060
Why?
Peak Expiratory Flow Rate
1
2006
13
0.060
Why?
Histamine H1 Antagonists
1
2006
2
0.060
Why?
Edema
1
2006
4
0.060
Why?
Electronics, Medical
1
2006
3
0.060
Why?
Phylogeny
1
2026
18
0.060
Why?
Pregnancy Trimester, Third
1
2026
22
0.060
Why?
Canada
1
2006
74
0.060
Why?
Adrenal Cortex Hormones
1
2006
66
0.060
Why?
Colorado
1
2006
171
0.060
Why?
Health Surveys
1
2006
226
0.060
Why?
Bayes Theorem
1
2026
75
0.060
Why?
Immunogenicity, Vaccine
1
2025
14
0.060
Why?
Polymerase Chain Reaction
2
2015
48
0.060
Why?
Ambulatory Care Facilities
2
2021
60
0.060
Why?
Personnel, Hospital
1
2005
7
0.060
Why?
Pregnancy Trimester, First
2
2017
45
0.050
Why?
Bias
2
2016
90
0.050
Why?
Models, Theoretical
1
2005
66
0.050
Why?
Sex Distribution
2
2017
164
0.050
Why?
Epitopes
1
2024
4
0.050
Why?
Community Health Centers
1
2024
58
0.050
Why?
Socioeconomic Factors
2
2017
571
0.050
Why?
Hispanic Americans
2
2019
350
0.050
Why?
Health Services Accessibility
1
2006
262
0.050
Why?
Anaphylaxis
2
2014
15
0.050
Why?
Kaposi Varicelliform Eruption
1
2003
1
0.050
Why?
Diagnostic Self Evaluation
2
2013
3
0.050
Why?
Toxoids
1
2023
3
0.050
Why?
Advisory Committees
1
2024
112
0.050
Why?
RNA-Directed DNA Polymerase
1
2022
3
0.050
Why?
Asymptomatic Infections
1
2022
6
0.050
Why?
Whole Genome Sequencing
1
2022
11
0.050
Why?
Texas
2
2013
40
0.050
Why?
Travel-Related Illness
1
2022
3
0.050
Why?
Poisson Distribution
2
2014
84
0.050
Why?
Early Detection of Cancer
2
2022
553
0.050
Why?
Saliva
1
2022
11
0.050
Why?
Human papillomavirus 18
1
2022
3
0.050
Why?
Human papillomavirus 16
1
2022
7
0.050
Why?
Telephone
1
2003
157
0.050
Why?
Injections, Intramuscular
2
2013
9
0.040
Why?
Thigh
2
2013
10
0.040
Why?
Arm
2
2013
4
0.040
Why?
Information Systems
1
2021
15
0.040
Why?
Alberta
1
2021
4
0.040
Why?
Carrier State
1
2021
7
0.040
Why?
Patient Acuity
1
2021
9
0.040
Why?
Reproducibility of Results
1
2002
346
0.040
Why?
Vaccines, Conjugate
2
2013
59
0.040
Why?
Health Facilities
1
2020
16
0.040
Why?
Israel
1
2020
2
0.040
Why?
Australia
1
2020
26
0.040
Why?
Global Health
1
2020
26
0.040
Why?
Drug Hypersensitivity
1
2019
8
0.040
Why?
Myocardial Infarction
1
2002
215
0.040
Why?
Appendicitis
1
2019
14
0.040
Why?
Continental Population Groups
1
2021
255
0.040
Why?
History, 21st Century
1
2019
24
0.040
Why?
Delivery of Health Care
1
2023
374
0.040
Why?
Cytological Techniques
1
2019
2
0.040
Why?
Cerebrovascular Disorders
1
2019
29
0.040
Why?
Pancreatitis
1
2019
54
0.040
Why?
Ethnic Groups
1
2021
418
0.030
Why?
Feces
1
2018
90
0.030
Why?
Venous Thrombosis
1
2017
23
0.030
Why?
Respiratory Sounds
1
2017
10
0.030
Why?
Pulmonary Embolism
1
2017
46
0.030
Why?
Outpatients
1
2018
99
0.030
Why?
Live Birth
1
2017
7
0.030
Why?
Behavior
1
2017
14
0.030
Why?
Family Health
1
2017
40
0.030
Why?
Social Marketing
1
2017
12
0.030
Why?
Infant, Low Birth Weight
1
2017
30
0.030
Why?
Cesarean Section
1
2017
34
0.030
Why?
Trust
1
2017
33
0.030
Why?
Educational Status
1
2017
163
0.030
Why?
Pregnancy Trimesters
1
2016
27
0.030
Why?
Maternal Age
1
2016
73
0.030
Why?
Observational Studies as Topic
1
2016
44
0.030
Why?
Linear Models
1
2016
187
0.030
Why?
Genotyping Techniques
1
2015
24
0.030
Why?
Ribonuclease P
1
2015
2
0.030
Why?
Biomarkers, Pharmacological
1
2015
5
0.030
Why?
Vasculitis
1
2014
2
0.030
Why?
Chills
1
2014
3
0.030
Why?
Myalgia
1
2014
10
0.030
Why?
Cough
1
2014
20
0.030
Why?
Dietary Supplements
1
2014
83
0.030
Why?
Encephalitis
1
2014
4
0.030
Why?
Absenteeism
1
2014
20
0.030
Why?
Cooperative Behavior
1
2014
84
0.030
Why?
Antibody Specificity
1
2013
1
0.030
Why?
Guillain-Barre Syndrome
1
2014
17
0.030
Why?
Nasopharynx
1
2013
1
0.030
Why?
Oropharynx
1
2013
1
0.030
Why?
Nasal Cavity
1
2013
2
0.030
Why?
Activities of Daily Living
1
2014
71
0.030
Why?
Observation
1
2013
20
0.020
Why?
Epidemiologic Methods
1
2013
67
0.020
Why?
Heptavalent Pneumococcal Conjugate Vaccine
1
2013
15
0.020
Why?
Self-Assessment
1
2013
14
0.020
Why?
Papanicolaou Test
1
2013
36
0.020
Why?
Neoplasm Grading
1
2013
43
0.020
Why?
Fetal Mortality
1
2013
2
0.020
Why?
Vaginal Smears
1
2013
47
0.020
Why?
Fetal Death
1
2013
7
0.020
Why?
Vaccines, Acellular
1
2012
11
0.020
Why?
Quality Control
1
2012
37
0.020
Why?
Ultrasonography
1
2013
32
0.020
Why?
Acute Disease
1
2013
144
0.020
Why?
Forecasting
1
2013
67
0.020
Why?
Likelihood Functions
1
2012
45
0.020
Why?
Smoking
1
2014
373
0.020
Why?
Alcohol Drinking
1
2014
298
0.020
Why?
Self Report
1
2013
248
0.020
Why?
Proportional Hazards Models
1
2013
657
0.020
Why?
Bell Palsy
1
2011
14
0.020
Why?
Prognosis
1
2013
568
0.020
Why?
Monitoring, Immunologic
1
2011
4
0.020
Why?
Safety Management
1
2011
13
0.020
Why?
Vulnerable Populations
1
2011
35
0.020
Why?
Drug Administration Schedule
1
2009
94
0.020
Why?
Gastrointestinal Diseases
1
2009
26
0.020
Why?
African Americans
1
2011
394
0.020
Why?
Medicaid
1
2009
189
0.020
Why?
Iowa
1
2005
38
0.010
Why?
Respiratory Function Tests
1
2005
26
0.010
Why?
Epidemiologic Studies
1
2005
25
0.010
Why?
Systems Integration
1
2005
4
0.010
Why?
Knowledge Bases
1
2005
4
0.010
Why?
Apgar Score
1
2005
5
0.010
Why?
Body Height
1
2005
54
0.010
Why?
Predictive Value of Tests
1
2005
325
0.010
Why?
Concepts (441)
Explore
_
Co-Authors (37)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_
-->

© 2026 Kaiser Permanente

Your Privacy Choices